8.1 Behavioral & Psychosocial Care

Why This Matters on the PCCN

Behavioral/Psychosocial content is only 3% of the PCCN blueprint, but it shows up disproportionately in scenario-based items because progressive care nurses manage acute alcohol/substance withdrawal, agitation, and psychiatric comorbidity constantly alongside medical-surgical disease. Expect 3-5 items testing recognition, scoring tools, and the safest first intervention.

Alcohol Withdrawal Syndrome (AWS)

Alcohol depresses the CNS chronically through GABA-A receptor potentiation and NMDA-glutamate suppression. Abrupt cessation removes that depressant effect, producing a rebound hyperexcitable state.

Timeline (know this cold):

Not every patient progresses through all four phases, and DTs occurs in a minority (roughly 5% of hospitalized withdrawal patients), but any patient with heavy, sustained alcohol use who is NPO or admitted acutely is at risk and should be assessed proactively, not only after symptoms appear.

CIWA-Ar Protocol

The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, revised) is the standard scoring tool. It rates 10 domains — nausea/vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache, and orientation/clouding of sensorium — most scored 0-7 (orientation scored 0-4), for a maximum of 67.

• Score <8-10: mild; supportive care, frequent reassessment.
• Score 8-15: moderate; symptom-triggered benzodiazepine dosing.
• Score >15-20: severe; higher risk of seizure and DTs, more aggressive dosing, consider ICU-level monitoring.

Symptom-triggered dosing (medication given only when the score crosses a threshold) is preferred over fixed-schedule dosing because it individualizes total drug exposure, shortens treatment duration, and reduces oversedation compared with standing doses given regardless of symptom severity.

First-Line Pharmacology

Benzodiazepines are first-line because they are cross-tolerant with alcohol at the GABA-A receptor, effectively substituting for alcohol's CNS-depressant effect while allowing a controlled taper.

• Lorazepam — preferred in hepatic impairment or older adults; metabolized by glucuronidation (no active metabolites), intermediate half-life.
• Diazepam — long half-life with active metabolites, allows self-tapering effect but risk of accumulation in liver disease.
• Chlordiazepoxide — traditional oral agent, long-acting.

Adjuncts (never as monotherapy for withdrawal): thiamine before glucose (prevent precipitating Wernicke encephalopathy in a thiamine-depleted patient), folate, magnesium repletion, and IV fluids. Phenobarbital is an alternative/adjunct in refractory or benzodiazepine-resistant withdrawal in some protocols. Antipsychotics (e.g., haloperidol) may treat hallucinations/agitation but do not prevent seizures and are not a substitute for benzodiazepines.

Agitation, Delirium & De-Escalation Before Restraints

Agitation in the progressive care patient has a broad differential — withdrawal, hypoxia, sepsis, pain, urinary retention, medication effect, ICU delirium — and the nurse's first job is to rule out a reversible medical cause before labeling behavior as purely psychiatric.

De-escalation is required before restraints, except in a true emergency where danger is immediate:

1. Ensure a safe environment (remove hazards, adequate staff presence).
2. Verbal de-escalation: calm tone, simple language, validate feelings, offer choices, reduce stimulation.
3. Address reversible causes (pain, full bladder, hypoxia, withdrawal).
4. Offer PRN medication if ordered and appropriate.
5. Use the least restrictive intervention — restraints are always a last resort.
6. If restraints are unavoidable, they must be time-limited, ordered per facility/regulatory policy (a physician/LIP order with defined duration and required reassessment intervals), and the patient must be monitored and released as soon as clinically safe.

This "least restrictive, time-limited" principle is a Joint Commission and CMS Conditions of Participation requirement, and PCCN items frequently test recognizing it as the correct next step over jumping straight to restraint application.

Anxiety, Depression & Substance Use in Acute Illness

Acute critical illness itself is a major trigger for anxiety and depressive symptoms — unfamiliar environment, loss of control, sleep disruption, pain, and fear of death or disability. The progressive care nurse's role is recognition and referral, not diagnosis: screen using validated tools, communicate findings to the team, involve psychiatry/social work/chaplaincy as indicated, and maintain a therapeutic, non-judgmental relationship, especially with patients who have substance use disorder, where stigma can undermine care.

Suicidal ideation requires a validated screening tool (e.g., Columbia-Suicide Severity Rating Scale, C-SSRS) whenever risk factors are present (new diagnosis of serious illness, prior self-harm history, expressed hopelessness, substance withdrawal with depression). A positive screen triggers 1:1 continuous observation, removal of potential means of self-harm from the room, and psychiatric consultation — this is a direct patient-safety action, not a documentation-only step.